GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates A/S (OCSE:VIRO) » Definitions » Net Interest Income

ViroGates A/S (OCSE:VIRO) Net Interest Income : kr-0.68 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is ViroGates A/S Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. ViroGates A/S's net interest income for the three months ended in Mar. 2024 was kr-0.16 Mil. Its net interest income for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.68 Mil.

ViroGates A/S Net Interest Income Historical Data

The historical data trend for ViroGates A/S's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViroGates A/S Net Interest Income Chart

ViroGates A/S Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Interest Income
Get a 7-Day Free Trial -0.29 -0.25 -0.18 -0.03 -0.53

ViroGates A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.15 -0.20 -0.18 -0.16

ViroGates A/S Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ViroGates A/S Net Interest Income Related Terms

Thank you for viewing the detailed overview of ViroGates A/S's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

ViroGates A/S (OCSE:VIRO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates A/S (OCSE:VIRO) » Definitions » Net Interest Income
Comparable Companies
OCSE:SMSMED ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA ALGN XSWX:SOON SHSE:688271 ASX:COH LSE:SN. PODD OCSE:DEMANT BRKR BIO
Traded in Other Exchanges
N/A
Address
Banevaenget 13, Birkerod, DNK, DK-3460
Website
https://www.virogates.com
ViroGates A/S is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

ViroGates A/S (OCSE:VIRO) Headlines

No Headlines